| Emma Ye, | |
|
505 Parnassus Ave, San Francisco, CA 94143 | |
| (415) 476-7931 | |
| (415) 476-4818 |
| Full Name | Emma Ye |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 6 Years |
| Location | 505 Parnassus Ave, San Francisco, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215424304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | A174013 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ucsf Medical Center | San francisco, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 4284547274 | 563 |
News Archive
Plexus Information Systems, Inc., a market-leading provider of Anesthesia Information Management Systems (AIMS), announced today that Tufts Medical Center went live with Anesthesia Touch, a full-featured AIMS that automates the anesthesia documentation process.
Neuralstem, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.
A pioneering method, developed at Chalmers University of Technology, has demonstrated its potential in a large study, showing that metabolic fingerprints from blood samples could render important new knowledge on the connection between food and health.
As part of its series on the relationships between human, animal and environmental health, titled "The Infection Loop," HuffPost Green examines how changes in climate and landscape, human movement, agricultural practices, and microbe adaptation are affecting the spread of malaria.
› Verified 4 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881763597 PECOS PAC ID: 4284547274 Enrollment ID: O20031106000389 |
News Archive
Plexus Information Systems, Inc., a market-leading provider of Anesthesia Information Management Systems (AIMS), announced today that Tufts Medical Center went live with Anesthesia Touch, a full-featured AIMS that automates the anesthesia documentation process.
Neuralstem, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.
A pioneering method, developed at Chalmers University of Technology, has demonstrated its potential in a large study, showing that metabolic fingerprints from blood samples could render important new knowledge on the connection between food and health.
As part of its series on the relationships between human, animal and environmental health, titled "The Infection Loop," HuffPost Green examines how changes in climate and landscape, human movement, agricultural practices, and microbe adaptation are affecting the spread of malaria.
› Verified 4 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
Plexus Information Systems, Inc., a market-leading provider of Anesthesia Information Management Systems (AIMS), announced today that Tufts Medical Center went live with Anesthesia Touch, a full-featured AIMS that automates the anesthesia documentation process.
Neuralstem, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.
A pioneering method, developed at Chalmers University of Technology, has demonstrated its potential in a large study, showing that metabolic fingerprints from blood samples could render important new knowledge on the connection between food and health.
As part of its series on the relationships between human, animal and environmental health, titled "The Infection Loop," HuffPost Green examines how changes in climate and landscape, human movement, agricultural practices, and microbe adaptation are affecting the spread of malaria.
› Verified 4 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
Plexus Information Systems, Inc., a market-leading provider of Anesthesia Information Management Systems (AIMS), announced today that Tufts Medical Center went live with Anesthesia Touch, a full-featured AIMS that automates the anesthesia documentation process.
Neuralstem, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.
A pioneering method, developed at Chalmers University of Technology, has demonstrated its potential in a large study, showing that metabolic fingerprints from blood samples could render important new knowledge on the connection between food and health.
As part of its series on the relationships between human, animal and environmental health, titled "The Infection Loop," HuffPost Green examines how changes in climate and landscape, human movement, agricultural practices, and microbe adaptation are affecting the spread of malaria.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emma Ye, 505 Parnassus Ave, San Francisco, CA 94143 Ph: (415) 476-7931 | Emma Ye, 505 Parnassus Ave, San Francisco, CA 94143 Ph: (415) 476-7931 |
News Archive
Plexus Information Systems, Inc., a market-leading provider of Anesthesia Information Management Systems (AIMS), announced today that Tufts Medical Center went live with Anesthesia Touch, a full-featured AIMS that automates the anesthesia documentation process.
Neuralstem, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.
A pioneering method, developed at Chalmers University of Technology, has demonstrated its potential in a large study, showing that metabolic fingerprints from blood samples could render important new knowledge on the connection between food and health.
As part of its series on the relationships between human, animal and environmental health, titled "The Infection Loop," HuffPost Green examines how changes in climate and landscape, human movement, agricultural practices, and microbe adaptation are affecting the spread of malaria.
› Verified 4 days ago
Dr. Shannon Walker, Hospitalist Medicare: Medicare Enrolled Practice Location: 112 Parnassus Ave Apt 4, San Francisco, CA 94117 Phone: 571-271-8343 | |
Elizabeth A. Andrews, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000 | |
Deborah Chiarucci, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000 | |
Dr. Sneha Kemkar, Hospitalist Medicare: Medicare Enrolled Practice Location: 3700 California St, San Francisco, CA 94118 Phone: 423-309-6170 | |
Dr. Fiona Henderson, Hospitalist Medicare: Medicare Enrolled Practice Location: 3555 Cesar Chavez Street, San Francisco, CA 94110 Phone: 415-647-8600 Fax: 415-641-6823 | |
Todd A. Levine, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 2200 Ofarrell St, San Francisco, CA 94115 Phone: 415-833-2000 | |
Jeannie Tran, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-476-7931 Fax: 415-476-4818 |